Language
FDA advisers vote against Lexicon Pharma's add-on drug for type 1 diabetes | Reuters

News

HomeHome / News / FDA advisers vote against Lexicon Pharma's add-on drug for type 1 diabetes | Reuters
search
RECENT NEWS

Jun 21, 2023

Odyssey Marine Exploration Announces Partnership with Ocean Minerals LLC for a New Cook Islands Exploration Project

Aug 01, 2023

Analysis of the impact of DGAT1 p.M435L and p.K232A variants on pre

Sep 06, 2023

Could ultra

Oct 10, 2023

Sunrise Group among the world's top ten chemical distributors

Oct 14, 2023

Orally Disintegrating Tablet Excipient Market Research Report 2023

SEND YOUR INQUIRY
SUBMIT

Nov 01, 2024

FDA advisers vote against Lexicon Pharma's add-on drug for type 1 diabetes | Reuters

Sign up here. Reporting by Sneha S K and Sruthi Narasimha Chari in Bengaluru; Editing by Shailesh Kuber and Maju Samuel Our Standards: The Thomson Reuters Trust Principles., opens new tab

Sign up here.

Reporting by Sneha S K and Sruthi Narasimha Chari in Bengaluru; Editing by Shailesh Kuber and Maju Samuel

Our Standards: The Thomson Reuters Trust Principles., opens new tab